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Median sternotomy (MS) is the conventional 
approach for mitral valve surgery. In the late 
1990s, minimally invasive mitral valve surgery 
(MIMVS) was introduced to the surgical options to 
manage mitral valve diseases [1]. This procedure 
can minimize surgical trauma, operative mortality, 
morbidity, and improve the quality of life. The 
reduced incision length may be of importance to 
young females and elders [2]. MIMVS has a limited 
operative field, which may negatively affect the 
outcomes and increase the risk of intraoperative 
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Abstract 
Background: The advantages of minimally invasive mitral valve surgery over the 
conventional approach is still debated. This study aimed to evaluate early outcomes 
after mitral valve replacement (MVR) using the right mini-thoracotomy (RMT) versus 
median sternotomy (MS). 
Methods: We prospectively included 60 patients who had MVR from May 2015 to 
June 2017. We classified patients into two groups; Group A (n= 30) had RMT, and 
Group B (n= 30) had MS. Postoperative pain score, wound satisfaction, and clinical 
and echocardiographic outcomes were compared between both groups.  
Results: The mean age was 39.90 ± 12.34 years in Group A and 45.75 ± 13.10 years 
in Group B (p= 0.08). Preoperative and echocardiographic data showed no statistical 
significance difference between the groups. Group A had longer aortic cross-clamp 
(118.85 ± 40.56 vs. 70.75 ± 24.81 minutes, p<0.001) and cardiopulmonary bypass 
times (186.70 ± 67.44 vs. 104.65 ± 42.60 minutes, p<0.001).  Group B had more blood 
loss (565 ± 344.3 vs. 241.5 ±89.16 ml/24 hours, p<0.001). The median pain score was 
1 (range: 1- 3) in Group A and 4 (2- 8) in Group B (p<0.001), and the median wound 
satisfaction was 1.5 (1- 4) in Group A and 4 (1- 7) in Group B (p<0.001).  Wound 
infection occurred in 1 (3.3%) patient in Group A and 6 (20%) patients in Group B 
(p=0.04).  
Conclusion: Mitral valve replacement through the right mini-thoracotomy could be 
a safe alternative to median sternotomy. The right mini-thoracotomy was associated 
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myocardial and cerebral complications [3]. On the 
other hand, several surgeons believe that the 
technique is safe and reproducible with good 
cosmetic results [4]. 
It is not known whether the potential benefits 
of The MIMVS could outweigh the potential 
drawbacks of limited operative exposure, more 
prolonged cardiopulmonary bypass, and aortic 
cross-clamp times [5]. This study compared 
postoperative outcomes after mitral valve 
replacement (MVR) using the right mini-
thoracotomy (RMT) versus conventional median 
sternotomy (MS). 
Patients and Methods: 
Design 
This prospective observational study included 
60 patients who had MVR between May 2015 to 
June 2017. The patients were grouped into two 
equal groups. The assignment to each group was 
based on the surgeons' choice and experience. 
Groups and technique 
Group "A" patients underwent MVR using 
RMT, and Group B included patients who had MS. 
In Group A, general anesthesia was conducted 
with a double-lumen endotracheal tube (DLT) with 
full monitoring. The patient was fully draped in the 
supine position, leaving two groin areas and right 
hemithorax exposed. We performed a 6-5 cm RMT 
incision at the 4th intercostal space (ICS), between 
mid-clavicular and anterior axillary lines at the 
sub-mammary crease. Using DLT, the right lung 
was deflated, and the pleural cavity was opened. 
Zero angle camera-connected to a screen was 
introduced into the pleural cavity through a 12 
mm port at 4th ICS at the midaxillary line. The 
pericardium was inspected and opened 
longitudinally anterior to the phrenic nerve from 
the inferior vena cava (IVC) to the superior vena 
cava (SVC). Through 4 cm incision 2 cm below the 
inguinal ligament, cannulation of the femoral vein 
and artery was made. We used a soft tissue 
retractor at the RMT incision. A long cardioplegia 
cannula (CC) was inserted at the ascending aorta. 
Chitwood aortic cross-clamp (ACC) was inserted 
through 2nd ICS to occlude the aorta distal to the 
CC. Cardioplegia solution was infused to arrest the 
heart. Perfusionist goes down with temperature 
to 32 °C.  
In group "B," 30 patients had MVR through MS. 
In this approach, the patient was positioned 
supine after general anesthesia with an 
endotracheal tube and full monitoring. The 
patient was fully draped, leaving all chest exposed 
from the suprasternal notch to level below the 
xiphoid process by 2 inches. The incision started 
from just below the suprasternal notch to the 
xiphoid process. Central cannulation was done 
with the aortic cannula in the ascending aorta and 
bicaval in the superior and inferior vena cava (SVC, 
IVC). We performed MVR with the same steps in 
both groups.
Table 1: Preoperative and operative data. Continuous variables are presented as mean and SD and categorical variables 
as number and percentages 
Group A (n= 30) Group B (n= 30) P-value 
Age (years) 39.90 ± 12.34 45.75 ± 13.10 0.08 
BMI (Kg/m2) 25.45 ± 2.31 25.68 ± 2.47 0.71 
Atrial fibrillation 15 (50%) 21 (70%) 0.2 
Ejection fraction (%) 62.20 ± 7.33 62.15 ± 8.32 0.98 
RV diameter (cm) 2.13 ± 0.26 2.27 ± 0.47 0.16 
PAP (mmHg) 55.65 ± 12.73 59.30 ± 15.31 0.32 
LA diameter (cm) 5.48 ± 0.84 5.46 ± 0.67 0.92 
ACC (minutes) 118.85 ± 40.56 70.75 ± 24.81 <0.0001 
CBP (minutes) 186.70 ± 67.44 104.65 ± 42.60 <0.0001 
TOT (minutes)  300.75 ± 74.50 237.00 ± 22.15 <0.0001 
ACC: aortic cross-clamp; BMI: body mass index; CBP: cardiopulmonary bypass; EF: ejection fraction; LA: 
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Table 2: Postoperative data. Continuous variables are presented as mean and SD or median (range) and categorical 
variables as number and percentages 
Group A (n=30) Group B (n=30) P-value 
MV (Hours)  6.00 ± 3.63 7.10 ± 2.00 0.15 
ICU (Hours)  48.80 ± 15.55 49.75 ± 26.55 0.87 
Blood loss (ml/24Hr) 241.5 ±89.16 565 ± 344.3 <0.001 
Blood transfusion (Units)  1.05 ± 1.00 1.30 ± 0.73 0.27 
Pain score (mean) 1 (1- 3) 4 (2- 8) <0.001 
Wound satisfaction (mean) 1.5 (1- 4) 4 (1- 7) <0.001 
Wound infection (within 1 week) 1 (3.3%) 6 (20%) 0.04 
ICU: intensive care unit; MV: mechanical ventilation 
Data 
Each patient underwent full history taking, 
clinical assessment, and preoperative laboratory, 
and radiological examinations. The 
echocardiographic assessment included 
measurement of the left ventricular ejection 
fraction (LVEF), the left atrial size (LA), right 
ventricle diameter (RV), and the pulmonary artery 
pressure (PAP). 
Postoperatively, the patient was transferred 
intubated to the intensive care unit (ICU). We 
reported the duration of mechanical ventilation 
(MV), blood loss, need for blood transfusion, and 
ICU stay duration.  
Questionnaires were conducted to assess the 
degree of pain related to the surgical wound using 
the visual analog scale and the wound's cosmetic 
result [6]. Follow up was carried out in the 
outpatient clinic postoperatively. The 6th-month 
postoperative TTE was routinely done to exclude 
pericardial effusion presence, ensuring a well-
functioning mitral valve. 
Statistical analysis: 
Quantitative variables were expressed as 
mean and SD and compared with the t-test or 
Mann-Whitney test. Qualitative data were 
expressed as number (n) and percentage and 
compared with the Chi-square test or Fisher exact 
test. Statistical significance was tested using an 
IBM compatible computer and IBM SPSS statistics 
(version 15; SPSS Inc., Chicago, Illinois, USA). A p-
value of less than 0.05 was considered statistically 
significant. 
Results 
Preoperative and operative data 
The mean age was 39.90 ± 12.34 years in 
Group A and 45.75 ± 13.10 years in Group B. 
Preoperative and echocardiographic data showed 
no statistical significance difference between the 
groups. Aortic cross-clamp, CBP, and total 
operative times were significantly longer in 
Group A (Table 1). 
Postoperative outcomes 
Blood loss was significantly more in Group B, 
and pain score, wound satisfaction (including 
cosmetic-visual analog scale (VAS), patient 
satisfaction-VAS), and wound infection were 
better in Group A. While there was no difference 
in the duration of MV, blood transfusion, and ICU 
stay (Table 2). On comparing the 6th-month 
postoperative echocardiographic findings, we 
detected no significant difference between both 
groups (Table 3). 
Table 3: The 6th-month postoperative echo-cardiographic 







EF (%)  61.80 ± 6.67 62.65 ± 8.99 0.68 
RV (cm)    1.95 ± 0.20 1.95 ± 0.52 0.968 
PAP (mmHg)  31.50 ± 3.49 32.35 ± 4.51 0.42 
LA (cm) 4.55 ± 0.49 4.81 ± 0.56 0.06 
EF: ejection fraction, LA: left atrium; RV: right 
ventricle, PAP: pulmonary artery pressure 
Discussion 
Minimally invasive mitral valve surgery is 
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obtained, including reducing surgical trauma, 
decreased bleeding and postoperative pain, 
reduced incidence of sternal wound infections, 
reduced length of hospital stay, and shortened 
recovery period after surgery [7]. 
In this study, we compared the outcomes after 
MVR through RMT vs. MS. the mean age and BMI 
matched similar studies [8,9]. While in comparison 
with a study done by EL-Fiky and associates, both 
groups were relatively older [10]. The mean age 
was 22 ± 10 years for the test group and 23 ± 9 
years for the control group.  But this was lower 
than the mean age in other studies [11]. That may 
be due to rheumatic etiology, which was the most 
common cause of valve pathology in both groups 
[10]. Both groups had similar preoperative 
echocardiographic parameters comparable with 
other studies [10-12]. 
In Group "A," ACC and CPB were significantly 
longer than Group "B." Similar results were found 
in other studies [5,12,13]. This could be 
attributed to the more technically demanding 
and time-consuming technique. While in another 
study by Iribane and coworkers [14], ACC for 
MIMVS decreased after considerable time 
because of the learning curve. Additionally, other 
authors reported significantly longer total cross-
clamp time and total bypass time in minimally 
invasive mitral valve surgery [8,9]. In another 
study by Badkhal and associates [11], CPB time 
was 142.5 ± 25.1 in MIMVS and 126.7±27.2 in 
MS. Modi and coworkers [5] reported that CPB 
and ACC times were longer with MIMVS, but they 
suggested that ACC and CPB can be reduced with 
experience. Certain high-volume centers reported 
shorter operative times [15]. 
In this study, total operative time in Group "A" 
was significantly longer than that in Group "B." A 
similar result was found in another relevant 
meta-analysis of 9 studies by Cheng and 
associates [12]. Other studies showed non-
significantly longer operative time [11, 16]. This 
increase in operative times may be due to new 
steps during MIMV, e.g., peripheral cannulation, 
using long-shafted instruments in a small 
operative field. These steps need to be mastered 
during the learning curve. 
Postoperative bleeding in Group "A" was 
significantly reduced than that of Group "B" and 
the need for blood transfusion was significantly 
lower. Ideally, chest tubes are removed when 
drainage is less than 100mL over 8 hours [17]. 
Reduction in postoperative bleeding and 
transfusion requirements has been suggested as a 
potential advantage of MIMVS. This benefit is 
important as it decreases morbidity and mortality 
associated with transfusions and re-exploration 
for bleeding [18]. Ding and colleagues suggested 
that one of the main advantages of MIMVS is the 
reduction in blood loss and reoperation for 
bleeding [13]. 
In the current study, mechanical ventilation 
time and ICU stay were shorter in Group "A," but 
both were not significant. Similar results were 
found in other studies [11, 16]. Other studies 
reported significantly shorter mechanical 
ventilation time and ICU stay [8, 9, 19]. Another 
meta-analysis of 15 studies showed that 
mechanical ventilation time and ICU stay were 
significantly reduced [12]. On the other hand, 
Ding and his colleagues reported that prolonged 
ventilation in MS patients might be attributed to 
postoperative respiratory complications [13]. 
There was no strong evidence to confirm this 
result. The keys to successful early extubation 
include an appropriate balance of sedation and 
analgesia. 
In our study, postoperative pain assessed with 
the visual analog scale was reduced significantly in 
Group "A" than that in Group" B," which was 
similar to another study [20]. Compared with MS, 
thoracotomy incisions were associated with less 
pain, discomfort, and postoperative analgesics. 
The most insightful evidence comes from 2 studies 
[21,22]. They reported that patients undergoing 
surgery via a minimally invasive approach as their 
second procedure, their recovery was faster with 
less pain than their original MS. 
In this study, wound satisfaction was 
significantly higher in Group "A" than Group "B." 
This finding was observed in another study by 
Ding and coworkers [13], who reported 282 of 
308 patients (91.5%) who were satisfied with the 
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In the current study, there were no significant 
differences in postoperative echocardiographic 
data between both groups. These results are 
similar to other studies [23]. In their meta-
analysis [12], Cheng and coworkers reported no 
significant difference in mitral valve leak or 
insufficiency, percentage of patients who 
developed infective endocarditis, and no 
difference in freedom from valve-related 
reoperation between groups at one-year follow-
up. Gammie and associates [24] reported that 
reoperation for valve dysfunction was 
insignificant for MIMVS. Brittain and coworkers 
[25] reported similar results, with a mean follow-
up of 19.1 ± 16.4 months. There was a significant 
reduction in right ventricular systolic pressure 
(RVSP) from 49.9 ± 16.2 to 41.7 ± 13.7 mmHg and 
a pattern toward a decline in the LA dimension. 
They reported a decrease in mean PAP. Dokhan 
and associates reported similar results as regards 
a decrease in mean PAP and LA diameter. PAP 
was 30.20±2.09 mmHg in 3 months postoperative 
TTE. LA diameter decreases to 4.38±0.51cm and 
4.49±0.52 cm in both groups in their study [9]. 
Limitations: 
This study was limited by small sample size, 
short-term follow-up, and inter-observer 
variability in interpreting the echocardiographic 
findings. 
Conclusion 
Mitral valve replacement through the right 
mini-thoracotomy could be a safe alternative to 
median sternotomy. The right mini-thoracotomy 
was associated with longer operative times but 
better pain and wound satisfaction scores and 
lower wound infection.   
Conflict of interest: Authors declare no conflict of 
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